Drugs / AZD8075
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00829127 | Jan 2009 | — | AstraZeneca | Withdrawn | No outcome recorded |
| Phase 1 | NCT00787072 | Oct 2008 → Jan 2009 | — | AstraZeneca | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD8075 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00829127 ↗ |
| Modality | Small molecule | — CHEMBL5095222 ↗ |
| Route | Oral | “Single dose, the starting dose will be 7 mg, oral suspension” NCT00787072 ↗ |